The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
Open accessAbstract
BACKGROUND Liver cirrhosis is a major cause of death worldwide. Cirrhosis develops after a long asymptomatic period of fibrosis progression, with the diagnosis frequently occurring late, when major complications or cancer develop. Few reliable tools exist for timely identification of individuals at risk of cirrhosis to allow for early intervention. We aimed to develop a novel score to identify individuals at risk for future liver-related outcomes. METHODS We derived the LiverRisk score from an international prospective cohort of individuals from six countries without known liver disease from the general population, who underwent liver fibrosis assessment by transient elastography. The score included age, sex, and six standard laboratory variables. We created four groups: minimal risk, low risk, medium risk, and high risk according to selected cutoff values of the LiverRisk score (6, 10, and 15). The model's discriminatory accuracy and calibration were externally validated in two prospective cohorts from the general population. Moreover, we ascertained the prognostic value of the score in the prediction of liver-related outcomes in participants without known liver disease with median follow-up of 12 years (UK Biobank cohort). FINDINGS We included 14 726 participants: 6357 (43·2%) in the derivation cohort, 4370 (29·7%) in the first external validation cohort, and 3999 (27·2%) in the second external validation cohort. The score accurately predicted liver stiffness in the development and external validation cohorts, and was superior to conventional serum biomarkers of fibrosis, as measured by area under the receiver-operating characteristics curve (AUC; 0·83 [95% CI [0·78-0·89]) versus the fibrosis-4 index (FIB-4; 0·68 [0·61-0·75] at 10 kPa). The score was effective in identifying individuals at risk of liver-related mortality, liver-related hospitalisation, and liver cancer, thereby allowing stratification to different risk groups for liver-related outcomes. The hazard ratio for liver-related mortality in the high-risk group was 471 (95% CI 347-641) compared with the minimal risk group, and the overall AUC of the score in predicting 10-year liver-related mortality was 0·90 (0·88-0·91) versus 0.84 (0·82-0·86) for FIB-4. INTERPRETATION The LiverRisk score, based on simple parameters, predicted liver fibrosis and future development of liver-related outcomes in the general population. The score might allow for stratification of individuals according to liver risk and thus guide preventive care. FUNDING None.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
Self-citationSepanlou, S. G., Safiri, S., Bisignano, C., Ikuta, K. S., Merat, S., Saberifiroozi, M., Poustchi, H., Tsoi, D., Colombara, D. V., Abdoli, A., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30349-8 · Cited by 1,714
Ginès, P., Krag, A., Abraldes, J. G., Solà, E., Fabrellas, N., & Kamath, P. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01374-x · Cited by 1,663
Self-citationProspective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
Sanyal, A. J., Van Natta, M. L., Clark, J., Neuschwander-Tetri, B. A., Diehl, A., Dasarathy, S., Loomba, R., Chalasani, N., Kowdley, K., Hameed, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029349 · Cited by 1,146
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Self-citationAngulo, P., Bugianesi, E., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Barrera, F., Haflidadottir, S., Day, C. P., & George, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.057 · Cited by 502
Serra-Burriel, M., Graupera, I., Torán, P., Thiele, M., Roulot, D., Wai-Sun Wong, V., Neil Guha, I., Fabrellas, N., Arslanow, A., Expósito, C., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.019 · Cited by 160
Self-citation
Cited by
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Self-citationEuropean Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) (2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 471
Israelsen, M., Francque, S., Tsochatzis, E. A., & Krag, A. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01811-7 · Cited by 348
Self-citationMetabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W. S., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki-Järvinen, H., & Loomba, R. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 293
Self-citationYang, L., Zhang, Y., Hong, X., Zhang, K., Liu, B., Zhang, P., Tang, Q., Yu, J., Jin, X.-Z., Jin, X.-Z., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03502-z · Cited by 7
Metadata
- Authors
- Serra-Burriel, M., Juanola, A., Serra-Burriel, F., Thiele, M., Graupera, I., Pose, E., Pera, G., Grgurevic, I., Caballeria, L., Piano, S., van Kleef, L., Reichert, M., Roulot, D., Pericàs, J. M., Schattenberg, J. M., Tsochatztis, E. A., Guha, I. N., Garcia-Retortillo, M., Hernández, R., Hoyo, J., Fuentes, M., Expósito, C., Martínez, A., Such, P., Madir, A., Detlefsen, S., Tonon, M., Martini, A., Ma, A. T., Pich, J., Bonfill, E., Juan, M., Soria, A., Carol, M., Gratacós-Ginès, J., Morillas, R. M., Toran, P., Navarrete, J. M., Torrejón, A., Fournier, C., Llorca, A., Arslanow, A., de Koning, H. J., Cucchietti, F., Manns, M., Newsome, P. N., Hernáez, R., Allen, A., Angeli, P., de Knegt, R. J., Karlsen, T. H., Galle, P., Wong, V. W.-S., Fabrellas, N., Castera, L., Krag, A., Lammert, F., Kamath, P. S., Ginès, P., Alvarez, M., Andersen, P., Angeli, P., Ardèvol, A., Arslanow, A., Beggiato, L., Ben Abdesselam, Z., Bennett, L., Boutouria, B., Brocca, A., Broquetas, M. T., Caballeria, L., Calvino, V., Camacho, J., Capdevila, A., Carol, M., Castera, L., Cervera, M., Cucchietti, F., de Fuentes, A., de Knegt, R., de Koning, H. J., Detlefsen, S., Diaz, A., Diéguez Bande, J., Esnault, V., Fabrellas, N., Falcó, J. L., Fernández, R., Fournier, C., Fuentes, M., Galle, P., García, E., García-Retortillo, M., Garrido, E., Ginès, P., Gordillo Medina, R., Gratacós-Ginès, J., Graupera, I., Grgurevic, I., Guha, I. N., Guix, E., Hansen, J. K., Harris, R., Hernández Boluda, E., Hernández-Ibañez, R., Hoyo, J., Ikram, A., Incicco, S., Israelsen, M., Juan, M., Juanola, A., Kaiser, R., Kamath, P. S., Karlsen, T. H., Kjærgaard, M., Korenjak, M., Krag, A., Krawczyk, M., Laboulaye, P., Lambert, I., Lammert, F., Langkjær Sørensen, S., Laserna-Jiménez, C., Lazaro Pi, S., Ledain, E., Levy, V., Lindvig, K. P., Llorca, A., Londoño, V., Loyer, G., Ma, A. T., Madir, A., Manns, M., Marshall, D., Martí, M. L., Martínez, S., Martínez Sala, R., Masa-Font, R., Møller Jensen, J., Morillas, R. M., Muñoz, L., Nadal, R., Napoleone, L., Navarrete, J., Newsome, P. N., Nielsen, V., Pérez, M., Pericás-Pulido, J. M., Piano, S., Pich, J., Pose, E., Presas Escobet, J., Reichert, M., Riba, C., Roulot, D., Rubio, A. B., Sánchez-Morata, M., Schattenberg, J., Serra-Burriel, M., Serra-Burriel, F., Skovborg Just, L., Sonneveld, M., Soria, A., Stern, C., Such, P., Thiele, M., Tonon, M., Toran, P., Torrejón, A., Tsochatzis, E. A., van Kleef, L., van Wijngaarden, P., Velázquez, V., Viu, A., Weber, S. N., & Wildsmith, T.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2023-09
- Volume
- 402
- Issue
- 10406
- Pages
- 988-996
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4385691330
- Cited by
- 171
- References
- 8
- FWCI
- 28.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study. https://app.cochat.ai/papers/10.1016/s0140-6736(23)01174-1
- The paper
- Serra-Burriel, M., Juanola, A., Serra-Burriel, F., Thiele, M., Graupera, I., Pose, E., Pera, G., Grgurevic, I., Caballeria, L., Piano, S., van Kleef, L., Reichert, M., Roulot, D., Pericàs, J. M., Schattenberg, J. M., Tsochatztis, E. A., Guha, I. N., Garcia-Retortillo, M., Hernández, R., . . . Wildsmith, T. (2023). Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study. The Lancet. https://doi.org/10.1016/s0140-6736(23)01174-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.